Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.
PharmAccess Foundation, Amsterdam Institute for Global Health and Development, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. r.hamers@pharmaccess.org
Raph L
RL
Hamers
Rebecca
R
Oyomopito
Cissy
C
Kityo
Praphan
P
Phanuphak
Margaret
M
Siwale
Somnuek
S
Sungkanuparph
Francesca
F
Conradie
Nagalingeswaran
N
Kumarasamy
Mariette E
ME
Botes
Thira
T
Sirisanthana
Saade
S
Abdallah
Patrick C K
PC
Li
Nicoletta
N
Ngorima
Pacharee
P
Kantipong
Akin
A
Osibogun
Christopher K C
CK
Lee
Wendy S
WS
Stevens
Adeeba
A
Kamarulzaman
Inge
I
Derdelinckx
Yi-Ming Arthur
YM
Chen
Rob
R
Schuurman
Michèle
M
van Vugt
Tobias F
TF
Rinke de Wit
D000293:Adolescent; D000328:Adult; D017954:Africa South of the Sahara; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001208:Asia; D024882:Drug Resistance, Viral; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D008297:Male; D010139:Pacific Islands; D011159:Population Surveillance; D015397:Program Evaluation; D055815:Young Adult
D019380:Anti-HIV Agents